位置:成果数据库 > 期刊 > 期刊详情页
益气、化瘀、清热中药对胃癌前病变患者Th1/Th2免疫漂移的影响
  • ISSN号:1001-0408
  • 期刊名称:《中国药房》
  • 时间:0
  • 分类:R243.2[医药卫生—中医临床基础;医药卫生—中医学]
  • 作者机构:[1]金华市中心医院中医科,浙江金华321000
  • 相关基金:金华市科学技术研究计划项目(社会发展类重点项目)(No.2013-3-007)
中文摘要:

目的:以中药提取物为切入点,观察益气、化瘀、清热中药对胃癌前病变的治疗效果及辅助性Ⅴ型T细胞(Th1)、辅助性Ⅴ型T细胞(Th2)类细胞因子在治疗前后的表达情况。方法:将120例确诊为慢性萎缩性胃炎伴肠上皮化生和/或异型增生且符合中医气阴两虚、瘀热互结型的患者,随机分为益气组(西洋参茎叶总皂苷)、化瘀组(三七总皂苷)、清热组(盐酸小檗碱)、对照组(替普瑞酮),各30例,每组患者使用相对应的药物治疗。3个月后评价各组药物对胃癌前病变的治疗效果及Th1、Th2各细胞因子表达的影响。结果:与治疗前比较,治疗后4组患者证候积分、病理积分及Th2的细胞因子水平均下降,Th1的细胞因子水平上升,差异具有统计学意义(P〈0-05)。与对照组比较,3个中药组在阻止胃癌前病变病理进展、刺激Th1细胞因子分泌、抑制Th2细胞因子表达方面均更有优势,差异具有统计学意义(P〈0-05);与其他组别比较,化瘀组在阻止胃癌前病变病理进展方面更有优势,益气组在Th1/Th2免疫漂移的调节上具有较强的能力,差异均有统计学意义(P〈0-05)。结论:益气、化瘀、清热中药对胃癌前病变有一定的治疗作用,但在免疫调节及病理改变方面的具体作用强度不尽相同,如何优化配伍组合3种中药,值得进一步研究。

英文摘要:

OBJECTIVE: To observe the efficacy of medicines for Qi-tonifying, stasisi-dissolving and heat-clearing in the treatment of precancerous lesion of gastric cancer (PLGC) and the expressions of Thl/Th2 cytokines before and after treatment, with the pointcut of TCM extractions. METHODS: 120 patients with chronic atrophic gastritis with intestinal metaplasia and/or dyspla- sia, Qi and Yin deficiency and accumulation of blood and heat were randomly divided into Qi-tonifying group (Panax quinquefolium saponin) , stasisi-dissolving group (Panax notoginseng saponins), heat-clearing group (berberine hydrochloride) and control group (teprenone), 30 cases for each. All the patients were treated by corresponding medicines. After 3 months treatment, the effects of corresponding medicines on the efficacy and expressions of Thl/Th2 cytokines of PLGC were evaluated. RESULTS: Compared with before, the scores of symptom and pathological and level of Th2 cytokine in 4 groups were decreased and the level of Thl cytokine was increased, with significant difference (P〈0-05). Compared with control group, stopping pathological progress of PLGC, stimulating Thl cytokine secretion and inhibiting Th2 cytokine expression in other 3 groups were better, with significant dif- ference (P〈0-05) ; compared with other groups, stasisi-dissolving group had advantage on stopping pathological progress of PLGC, and Qi-tonifying group had advantage on adjusting Thl/Th2 immune drift, with significant differences (P〈0-05). CON- CLUSIONS: Medicines for Qi-tonifying, stasisi-dissolving and heat-clearing have certain efficacy in the treatment of PLGC. How- ever, it is different in the specific intensity of immune adjustment and pathological change. How to optimize and combine the 3 medicines is worthy of further study.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国药房》
  • 北大核心期刊(2014版)
  • 主管单位:中华人民共和国国家卫生和计划生育委员会
  • 主办单位:中国医院协会 中国药房杂志社
  • 主编:夏培元
  • 地址:重庆市渝中区大坪正街129号四环大厦8层
  • 邮编:400042
  • 邮箱:info@china-pharmacy.com.cn
  • 电话:023-89809898 68573988
  • 国际标准刊号:ISSN:1001-0408
  • 国内统一刊号:ISSN:50-1055/R
  • 邮发代号:78-33
  • 获奖情况:
  • 中国科技论文统计源期刊,中国期刊方阵“双效”期刊
  • 国内外数据库收录:
  • 俄罗斯文摘杂志,美国国际药学文摘,美国化学文摘(网络版),波兰哥白尼索引,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2014版)
  • 被引量:73319